Combination chemotherapy in the treatment of germ cell tumors containing choriocarcinoma in males and females.
D000293:Adolescent; D000328:Adult; D002822:Choriocarcinoma / Q000188:drug therapy* / Q000401:mortality; D006063:Chorionic Gonadotropin / Q000652:urine; D003520:Cyclophosphamide / Q000627:therapeutic use*; D003609:Dactinomycin / Q000627:therapeutic use*; D004407:Dysgerminoma / Q000188:drug therapy / Q000401:mortality; D005260:Female; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D009362:Neoplasm Metastasis; D009373:Neoplasms, Germ Cell and Embryonal / Q000188:drug therapy* / Q000401:mortality; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000401:mortality; D011247:Pregnancy; D011379:Prognosis; D012075:Remission, Spontaneous; D012186:Retroperitoneal Neoplasms / Q000188:drug therapy / Q000401:mortality; D013724:Teratoma / Q000188:drug therapy / Q000401:mortality; D013736:Testicular Neoplasms / Q000188:drug therapy / Q000401:mortality
D006063:Chorionic Gonadotropin; D003609:Dactinomycin; D003520:Cyclophosphamide; D008727:Methotrexate